Baraldi Patrícia T, Magro Angelo J, Matioli Fábio F, Marcussi Silvana, Lemke Ney, Calderon Leonardo A, Stábeli Rodrigo G, Soares Andreimar M, Correa Arlene G, Fontes Marcos R M
Departamento de Química, Universidade Federal de São Carlos (UFSCar), São Carlos, SP, Brazil.
Departamento de Bioprocessos e Biotecnologia, Faculdade de Ciências Agrárias, Universidade Estadual Paulista (UNESP), Botucatu, SP, Brazil; Instituto de Biotecnologia, Universidade Estadual Paulista (UNESP), Botucatu, SP, Brazil; Departamento de Física e Biofísica, Instituto de Biociências, Universidade Estadual Paulista (UNESP), Botucatu, SP, Brazil.
Biochimie. 2016 Feb;121:179-88. doi: 10.1016/j.biochi.2015.11.031. Epub 2015 Dec 14.
Metalloproteases play a fundamental role in snake venom envenomation inducing hemorrhagic, fibrigen(ogen)olytic and myotoxic effects in their victims. Several snake venoms, such as those from the Bothrops genus, present important local effects which are not efficiently neutralized by conventional serum therapy. Consequently, these accidents may result in permanent sequelae and disability, creating economic and social problems, especially in developing countries, leading the attention of the World Health Organization that considered ophidic envenomations a neglected tropical disease. Aiming to produce an efficient inhibitor against bothropic venoms, we synthesized different molecules classified as quinolinones - a group of low-toxic chemical compounds widely used as antibacterial and antimycobacterial drugs - and tested their inhibitory properties against hemorrhage caused by bothropic venoms. The results from this initial screening indicated the molecule 2-hydroxymethyl-6-methoxy-1,4-dihydro-4-quinolinone (Q8) was the most effective antihemorrhagic compound among all of the assayed synthetic quinolinones. Other in vitro and in vivo experiments showed this novel compound was able to inhibit significantly the hemorrhagic and/or proteolytic activities of bothropic crude venoms and isolated snake venom metalloproteases (SVMPs) even at lower concentrations. Docking and molecular dynamic simulations were also performed to get insights into the structural basis of Q8 inhibitory mechanism against proteolytic and hemorrhagic SVMPs. These structural studies demonstrated that Q8 may form a stable complex with SVMPs, impairing the access of substrates to the active sites of these toxins. Therefore, both experimental and structural data indicate that Q8 compound is an interesting candidate for antiophidic therapy, particularly for the treatment of the hemorrhagic and necrotic effects induced by bothropic venoms.
金属蛋白酶在蛇毒中毒过程中起着重要作用,可导致受害者出现出血、纤维蛋白(原)溶解和肌毒性作用。几种蛇毒,如矛头蝮属的蛇毒,具有重要的局部作用,而传统血清疗法无法有效中和这些作用。因此,这些中毒事件可能导致永久性后遗症和残疾,引发经济和社会问题,尤其是在发展中国家,这引起了世界卫生组织的关注,该组织将蛇咬伤中毒视为一种被忽视的热带病。为了研发一种针对矛头蝮蛇毒的有效抑制剂,我们合成了不同的分子,这些分子被归类为喹啉酮——一类低毒的化合物,广泛用作抗菌和抗分枝杆菌药物——并测试了它们对矛头蝮蛇毒引起的出血的抑制特性。初步筛选结果表明,在所有测定的合成喹啉酮中,分子2-羟甲基-6-甲氧基-1,4-二氢-4-喹啉酮(Q8)是最有效的抗出血化合物。其他体外和体内实验表明,即使在较低浓度下,这种新型化合物也能够显著抑制矛头蝮粗毒和分离的蛇毒金属蛋白酶(SVMPs)的出血和/或蛋白水解活性。还进行了对接和分子动力学模拟,以深入了解Q8对蛋白水解和出血性SVMPs抑制机制的结构基础。这些结构研究表明,Q8可能与SVMPs形成稳定的复合物,从而阻碍底物进入这些毒素的活性位点。因此,实验和结构数据均表明,Q8化合物是抗蛇毒疗法的一个有吸引力的候选药物,特别是用于治疗矛头蝮蛇毒引起的出血和坏死作用。